JT010 is primarily used in scientific research as a potent and selective inhibitor of TRPA1 (Transient Receptor Potential Ankyrin 1) channels. These channels are involved in various physiological processes, including pain sensation, inflammation, and respiratory functions. Researchers utilize JT010 to study the role of TRPA1 in these processes, particularly in understanding its contribution to chronic pain conditions and inflammatory diseases. By inhibiting TRPA1, JT010 helps elucidate potential therapeutic targets for pain management and other TRPA1-related disorders. Its application is crucial in developing new pharmacological strategies to treat conditions where TRPA1 activity is implicated.